The eye care supplement market is projected to be worth US$ 2,457.5 million in 2024. The market is likely to reach US$ 4,613.0 million by 2034. The market is further expected to surge at a CAGR of 6.5% during the forecast period 2024 to 2034.
| Attributes | Key Insights |
|---|---|
| Eye Care Supplement Market Estimated Size in 2024 | US$ 2,457.5 million |
| Projected Market Value in 2034 | US$ 4,613.0 million |
| Value-based CAGR from 2024 to 2034 | 6.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The scope for eye care supplement rose at a 6.0% CAGR between 2019 and 2023. The global market for eye care supplement is anticipated to grow at a moderate CAGR of 6.5% over the forecast period 2024 to 2034.
| Report Attributes | Details |
|---|---|
| Market Value in 2019 | US$ 1,809.9 million |
| Market Value in 2023 | US$ 2,301.8 million |
| CAGR from 2019 to 2023 | 6.0% |
The eye care supplement market experienced a significant growth during the historical period from 2019 to 2023. The aging global population was likely a significant driver, leading to a rise in age related eye conditions and an increased demand for eye care supplements. Rising awareness of the importance of preventive health measures and the role of nutrition in maintaining eye health likely contributed to the growth of the eye care supplement market.
The proliferation of digital devices and concerns about the impact of blue light on eye health may have driven the development and adoption of supplements targeting digital eye strain. Ongoing research and innovation in supplement formulations, including the use of scientifically proven ingredients, likely played a role in market growth.
The forecast period from 2024 to 2034 is expected to witness accelerated growth in the market. Continued advancements in supplement delivery systems and technology are expected to enhance the bioavailability and effectiveness of eye care supplements. The trend of personalized nutrition, possibly guided by genetic testing, may lead to the development of highly customized eye care supplement regimens.
Increased integration of digital tools, such as mobile apps for tracking eye health and supplement adherence, may enhance consumer engagement and contribute to market growth. The eye care supplement market may see increased expansion into emerging markets as healthcare awareness grows in those regions.
Clearer regulations and support for health claims related to eye health can enhance consumer trust and confidence, driving market growth. The adoption of holistic health approaches may lead to the development of supplements that address both eye health and overall well being. A growing understanding of the link between mental health and eye health can lead to the development of supplements targeting stress related eye issues.
Principal Consultant
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The below table showcases revenues in terms of the top 5 leading countries, spearheaded by the United States and China. The countries are expected to lead the market through 2034.
| Countries | Forecast CAGRs from 2024 to 2034 |
|---|---|
| The United States | 7.0% |
| Germany | 5.5% |
| The United Kingdom | 5.6% |
| China | 6.4% |
| India | 6.0% |
The eye care supplement market in the United States expected to expand at a CAGR of 7.0% through 2034. Growing awareness among the population of the United States about the importance of eye health and preventive measures has led to an increased interest in eye care supplements.
The broader trend toward preventive healthcare has influenced consumers to take proactive steps to maintain eye health, contributing to the demand for eye care supplements. Concerns about digital eye strain have risen, with the widespread use of digital devices in the United States. Eye care supplements addressing the effects of prolonged screen time have gained popularity.
The eye care supplement market in India is anticipated to expand at a CAGR of 6.0% through 2034. India is experiencing demographic changes, with an aging population. There is an increased risk of age related eye conditions, as individuals age in the country, which is expected to create a demand for supplements supporting eye health.
The expanding middle class population in India, coupled with increasing disposable income, provides consumers with the financial capacity to invest in health and wellness products, including eye care supplements.
The eye care supplement market in Germany is poised to expand at a CAGR of 5.5% through 2034. Government led health initiatives promoting preventive healthcare and wellness are expected to contribute to increased awareness and acceptance of eye care supplements in Germany.
Germany has stringent regulations for dietary supplements, providing consumers with confidence in the safety and quality of products. Regulatory support can positively influence market growth. The country has a culture that values an active lifestyle and fitness. The trend is likely to lead to the demand for supplements that support overall well being, including eye health.
Eye care supplement trends in China are taking a turn for the better. A 6.4% CAGR is forecast for the country from 2024 to 2034. Rapid urbanization and changing lifestyles in China have led to dietary shifts and increased reliance on processed foods. There is a growing interest in supplements to fill nutritional gaps.
The prevalence of e-commerce platforms in China facilitates easy access to a wide range of dietary supplements, making it convenient for consumers to purchase eye care supplements online. Traditional Chinese medicine places importance on holistic approaches to health. The cultural emphasis may contribute to the acceptance of supplements, including those for eye health.
The eye care supplement market in the United Kingdom is anticipated to expand at a CAGR of 5.6% through 2034. Collaborations between supplement manufacturers and healthcare professionals, such as ophthalmologists or optometrists, can enhance consumer trust and confidence in eye care supplements.
Deficiencies in essential vitamins and minerals, such as vitamin A, vitamin C, vitamin E, zinc, and omega-3 fatty acids, can impact eye health. Supplements addressing these deficiencies may see increased demand.
Growing consumer preference for natural and plant-based ingredients in supplements is expected to lead to the development of eye care supplements with botanical extracts and natural compounds known for their eye health benefits.
The below table highlights how lutein and zeaxanthin segment is projected to lead the market in terms of ingredients, and is expected to account for a share of 37.0% in 2024.
Based on dosage form, the tablet segment is expected to account for a share of 21.5% in 2024.
| Category | Shares in 2024 |
|---|---|
| Lutein and Zeaxanthin | 37.0% |
| Tablet | 21.5% |
Based on ingredients, the lutein and zeaxanthin segment is expected to continue dominating the eye care supplement market. The segment is expected to account for a share of 37.0% in 2024.
Lutein and zeaxanthin are carotenoids with strong antioxidant properties. Antioxidants help protect the eyes from oxidative stress caused by free radicals, contributing to overall eye health.
Lutein and zeaxanthin are particularly beneficial for maintaining macular health. The macula is a part of the retina responsible for central vision, and these carotenoids are known to accumulate in the macula, helping protect against age related macular degeneration.
Some studies suggest that higher dietary intake or supplementation of lutein and zeaxanthin may be associated with a reduced risk of developing cataracts, a common age related eye condition.
Lutein and zeaxanthin act as natural filters that protect the eyes from phototoxic damage caused by exposure to ultraviolet light. The protective effect contributes to overall eye health.
In terms of dosage form, the tablet segment is expected to continue dominating the eye care supplement market. The segment is expected to account for a share of 21.5% in 2024.
Tablets are a convenient and portable dosage form, making them easy for consumers to incorporate into their daily routines. The ease of storage and consumption contributes to the popularity of tablets as a preferred dosage form.
Tablets offer precise dosage control, ensuring that consumers receive consistent amounts of active ingredients, which is particularly important for eye care supplements where accurate dosing is essential for optimal results.
Tablets generally have a longer shelf life compared to some other dosage forms, providing stability for eye care supplements and reducing the likelihood of product degradation over time.
The manufacturing process for tablets is well established and standardized, allowing for efficient production and stringent quality control, which contributes to the reliability and consistency of tablet formulations.
The key strategies chosen by large companies include several growth strategies such as technology development, expansion as well and mergers and acquisitions to surge market share, reach and revenue.
| Attribute | Details |
|---|---|
| Estimated Market Size in 2024 | US$ 2,457.5 million |
| Projected Market Valuation in 2034 | US$ 4,613.0 million |
| Value-based CAGR 2024 to 2034 | 6.5% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in US$ million |
| Key Regions Covered | North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East & Africa |
| Key Market Segments Covered | Ingredients Dosage Form Route of Administration Indication Distribution Channel Region |
| Key Countries Profiled | The United States Canada Brazil Mexico Germany France France Spain Italy Russia Poland Czech Republic Romania India Bangladesh Australia New Zealand China Japan South Korea GCC countries South Africa Israel |
| Key Companies Profiled |
|
The market is expected to reach US$ 2,457.5 million in 2024.
The market is set to expand by a CAGR of 6.5% by 2034.
The market is forecast to reach US$ 4,613.0 million by 2034.
The United States is to be the top performing market, with a CAGR of 7.0% through 2034.
Lutein and Zeaxanthin segment is preferred, and is expected to account for a share of 37.0% in 2024.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Brand Mapping Analysis
3.1. Price v/s Product
3.2. Value for Money
3.3. Top-of-Mind Brands
3.4. Brand Portfolio-by Key Players
3.5. Brand Loyalty Mapping
3.6. Usage Pattern Overview
3.7. Branded vs Unbranded-Market Mix
4. Distribution Channel Wise Key Brand Positioning
4.1. Global Top Retailers and their Brand Offerings
4.1.1. Retail Pharmacy (Key Brands)
4.1.2. Hospital Pharmacy (Key Brands)
4.1.3. Diagnostic Centers (Key Brands)
4.1.4. Online Sales (Key Brands)
4.2. Retail Pricing Strategies
5. Consumer Buying Behavior Analysis
5.1. Functionality and Product Demand
5.1.1. Lutein and Zeaxanthin
5.1.2. Antioxidants
5.1.3. Omega-3 Fatty Acids
5.1.4. Coenzyme Q10
5.1.5. Flavonoids
5.1.6. Astaxanthin
5.1.7. Alpha-Lipoic Acid
5.1.8. Others
5.2. What factors do you consider when deciding to purchase Eye Care Supplements?
5.3. How important are product certifications when choosing Eye Care Supplements?
5.4. How important is the brand reputation and recognition when selecting Eye Care Supplements?
5.5. What marketing channels do you prefer for learning about new hair Eye Care Supplements?
5.6. How often do you purchase new hair Eye Care Supplements?
5.6.1. Once or More Every Month
5.6.2. Once Every 2 months
5.6.3. Once Every 6 Months
5.6.4. Once a Year
5.6.5. Less Than Once A Year
6. Market Trends & Dynamics
6.1. Per capita spending
6.2. Key Trends Impacting the Market
6.3. Product Innovation / Development Trends
6.3.1. Latest Trends and Demands
6.3.2. Latest Innovations and New Launches
6.4. Future Prospects of the Industry
6.5. Market Dynamics
6.5.1. Drivers
6.5.2. Restraints
6.6. Opportunity Analysis
7. Key Success Factors
7.1. New Product Launches
7.2. Technology Roadmap
7.3. PESTEL Analysis
7.4. Porter’s Analysis
7.5. Product Features/ USPs
7.6. Key Promotional Strategies, By Key Manufacturers
7.7. Regulatory Landscape
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Global GDP Growth Outlook
8.1.2. Global Healthcare Expenditure
8.1.3. Global Ophthalmic Drugs Market Outlook
8.2. Forecast Factors - Relevance & Impact
8.2.1. Key Player’s Historic Growth
8.2.2. Market Consolidation Activities
8.2.3. Formation
8.2.4. Growing Preference
8.2.5. Rising Cases of Macular Degeneration and Refractive Errors
8.3. Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Opportunity Analysis
9. Global Market Demand Value or Size (in US$ Million) Analysis 2019 to 2023 and Forecast, 2024 to 2034
9.1. Historical Market Value (US$ Million) Analysis, 2019 to 2023
9.2. Current and Future Market Value (US$ Million) Projections, 2024 to 2034
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Ingredients
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Ingredients, 2019 to 2023
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Ingredients, 2024 to 2034
10.3.1. Lutein and Zeaxanthin
10.3.2. Antioxidants
10.3.3. Omega-3 Fatty Acids
10.3.4. Coenzyme Q10
10.3.5. Flavonoids
10.3.6. Astaxanthin
10.3.7. Alpha-Lipoic Acid
10.3.8. Others
10.4. Market Attractiveness Analysis By Ingredients
11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) By Dosage Form, 2019 to 2023
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Dosage Form, 2024 to 2034
11.3.1. Tablet
11.3.2. Capsules
11.3.3. Gels
11.3.4. Liquid
11.3.5. Gummies
11.4. Market Attractiveness Analysis By Dosage Form
12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By Route of Administration, 2019 to 2023
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Route of Administration, 2024 to 2034
12.3.1. Oral
12.3.2. Topical
12.3.3. Parentral
12.4. Market Attractiveness Analysis By Route of Administration
13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
13.4. Introduction / Key Findings
13.5. Historical Market Size (US$ Million) Analysis By Indication, 2019 to 2023
13.6. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2024 to 2034
13.6.1. Age-related Macular Degeneration (AMD)
13.6.2. Cataract
13.6.3. Dry Eye Syndrome
13.6.4. Glaucoma
13.6.5. Others
13.7. Market Attractiveness Analysis By Indication
14. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
14.4. Introduction / Key Findings
14.5. Historical Market Size (US$ Million) By Distribution Channel, 2019 to 2023
14.6. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2024 to 2034
14.6.1. Retail Pharmacies
14.6.2. Hospital Pharmacies
14.6.3. Online Pharmacies
14.6.4. Opthalmic Stores
14.7. Market Attractiveness Analysis By Distribution Channel
15. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
15.4. Introduction
15.5. Historical Market Size (US$ Million) Analysis by Region, 2019 to 2023
15.6. Current Market Size (US$ Million) Analysis and Forecast by Region, 2024 to 2034
15.6.1. North America
15.6.2. Latin America
15.6.3. Europe
15.6.4. East Asia
15.6.5. South Asia
15.6.6. Oceania
15.6.7. Middle East and Africa (MEA)
15.7. Market Attractiveness Analysis By Region
16. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
16.4. Introduction
16.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
16.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
16.6.1. By Country
16.6.1.1. USA
16.6.1.2. Canada
16.6.2. By Ingredients
16.6.3. By Dosage Form
16.6.4. By Route of Administration
16.6.5. By Indication
16.6.6. By Distribution Channel
16.7. Market Attractiveness Analysis
16.7.1. By Country
16.7.2. By Ingredients
16.7.3. By Dosage Form
16.7.4. By Route of Administration
16.7.5. By Indication
16.7.6. By Distribution Channel
16.8. Market Trends
16.9. Key Market Participants - Intensity Mapping
16.10. Drivers and Restraints - Impact Analysis
16.11. Country Level Analysis & Forecast
16.11.1. USA Market Analysis
16.11.1.1. Introduction
16.11.1.2. Market Analysis and Forecast by Market Taxonomy
16.11.1.2.1. By Ingredients
16.11.1.2.2. By Dosage Form
16.11.1.2.3. By Route of Administration
16.11.1.2.4. By Indication
16.11.1.2.5. By Distribution Channel
16.11.2. Canada Market Analysis
16.11.2.1. Introduction
16.11.2.2. Market Analysis and Forecast by Market Taxonomy
16.11.2.2.1. By Ingredients
16.11.2.2.2. By Dosage Form
16.11.2.2.3. By Route of Administration
16.11.2.2.4. By Indication
16.11.2.2.5. By Distribution Channel
17. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
17.4. Introduction
17.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
17.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
17.6.1. By Country
17.6.1.1. Mexico
17.6.1.2. Brazil
17.6.1.3. Argentina
17.6.1.4. Rest of Latin America
17.6.2. By Ingredients
17.6.3. By Dosage Form
17.6.4. By Route of Administration
17.6.5. By Indication
17.6.6. By Distribution Channel
17.7. Market Attractiveness Analysis
17.7.1. By Country
17.7.2. By Ingredients
17.7.3. By Dosage Form
17.7.4. By Route of Administration
17.7.5. By Indication
17.7.6. By Distribution Channel
17.8. Market Trends
17.9. Key Market Participants - Intensity Mapping
17.10. Drivers and Restraints - Impact Analysis
17.11. Country Level Analysis & Forecast
17.11.1. Mexico Market Analysis
17.11.1.1. Introduction
17.11.1.2. Market Analysis and Forecast by Market Taxonomy
17.11.1.2.1. By Ingredients
17.11.1.2.2. By Dosage Form
17.11.1.2.3. By Route of Administration
17.11.1.2.4. By Indication
17.11.1.2.5. By Distribution Channel
17.11.2. Brazil Market Analysis
17.11.2.1. Introduction
17.11.2.2. Market Analysis and Forecast by Market Taxonomy
17.11.2.2.1. By Ingredients
17.11.2.2.2. By Dosage Form
17.11.2.2.3. By Route of Administration
17.11.2.2.4. By Indication
17.11.2.2.5. By Distribution Channel
17.11.3. Argentina Market Analysis
17.11.3.1. Introduction
17.11.3.2. Market Analysis and Forecast by Market Taxonomy
17.11.3.2.1. By Ingredients
17.11.3.2.2. By Dosage Form
17.11.3.2.3. By Route of Administration
17.11.3.2.4. By Indication
17.11.3.2.5. By Distribution Channel
18. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
18.4. Introduction
18.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
18.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
18.6.1. By Country
18.6.1.1. UK
18.6.1.2. Germany
18.6.1.3. Italy
18.6.1.4. France
18.6.1.5. Spain
18.6.1.6. Russia
18.6.1.7. BENELUX
18.6.1.8. Rest of Europe
18.6.2. By Ingredients
18.6.3. By Dosage Form
18.6.4. By Route of Administration
18.6.5. By Indication
18.6.6. By Distribution Channel
18.7. Market Attractiveness Analysis
18.7.1. By Country
18.7.2. By Ingredients
18.7.3. By Dosage Form
18.7.4. By Route of Administration
18.7.5. By Indication
18.7.6. By Distribution Channel
18.8. Market Trends
18.9. Key Market Participants - Intensity Mapping
18.10. Drivers and Restraints - Impact Analysis
18.11. Country Level Analysis & Forecast
18.11.1. UK Market Analysis
18.11.1.1. Introduction
18.11.1.2. Market Analysis and Forecast by Market Taxonomy
18.11.1.2.1. By Ingredients
18.11.1.2.2. By Dosage Form
18.11.1.2.3. By Route of Administration
18.11.1.2.4. By Indication
18.11.1.2.5. By Distribution Channel
18.11.2. Germany Market Analysis
18.11.2.1. Introduction
18.11.2.2. Market Analysis and Forecast by Market Taxonomy
18.11.2.2.1. By Ingredients
18.11.2.2.2. By Dosage Form
18.11.2.2.3. By Route of Administration
18.11.2.2.4. By Indication
18.11.2.2.5. By Distribution Channel
18.11.3. Italy Market Analysis
18.11.3.1. Introduction
18.11.3.2. Market Analysis and Forecast by Market Taxonomy
18.11.3.2.1. By Ingredients
18.11.3.2.2. By Dosage Form
18.11.3.2.3. By Route of Administration
18.11.3.2.4. By Indication
18.11.3.2.5. By Distribution Channel
18.11.4. France Market Analysis
18.11.4.1. Introduction
18.11.4.2. Market Analysis and Forecast by Market Taxonomy
18.11.4.2.1. By Ingredients
18.11.4.2.2. By Dosage Form
18.11.4.2.3. By Route of Administration
18.11.4.2.4. By Indication
18.11.4.2.5. By Distribution Channel
18.11.5. Spain Market Analysis
18.11.5.1. Introduction
18.11.5.2. Market Analysis and Forecast by Market Taxonomy
18.11.5.2.1. By Ingredients
18.11.5.2.2. By Dosage Form
18.11.5.2.3. By Route of Administration
18.11.5.2.4. By Indication
18.11.5.2.5. By Distribution Channel
18.11.6. Russia Market Analysis
18.11.6.1. Introduction
18.11.6.2. Market Analysis and Forecast by Market Taxonomy
18.11.6.2.1. By Ingredients
18.11.6.2.2. By Dosage Form
18.11.6.2.3. By Route of Administration
18.11.6.2.4. By Indication
18.11.6.2.5. By Distribution Channel
18.11.7. BENELUX Market Analysis
18.11.7.1. Introduction
18.11.7.2. Market Analysis and Forecast by Market Taxonomy
18.11.7.2.1. By Ingredients
18.11.7.2.2. By Dosage Form
18.11.7.2.3. By Route of Administration
18.11.7.2.4. By Indication
18.11.7.2.5. By Distribution Channel
19. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
19.4. Introduction
19.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
19.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
19.6.1. By Country
19.6.1.1. China
19.6.1.2. Japan
19.6.1.3. South Korea
19.6.2. By Ingredients
19.6.3. By Dosage Form
19.6.4. By Route of Administration
19.6.5. By Indication
19.6.6. By Distribution Channel
19.7. Market Attractiveness Analysis
19.7.1. By Country
19.7.2. By Ingredients
19.7.3. By Dosage Form
19.7.4. By Route of Administration
19.7.5. By Indication
19.7.6. By Distribution Channel
19.8. Market Trends
19.9. Key Market Participants - Intensity Mapping
19.10. Drivers and Restraints - Impact Analysis
19.11. Country Level Analysis & Forecast
19.11.1. China Market Analysis
19.11.1.1. Introduction
19.11.1.2. Market Analysis and Forecast by Market Taxonomy
19.11.1.2.1. By Ingredients
19.11.1.2.2. By Dosage Form
19.11.1.2.3. By Route of Administration
19.11.1.2.4. By Indication
19.11.1.2.5. By Distribution Channel
19.11.2. Japan Market Analysis
19.11.2.1. Introduction
19.11.2.2. Market Analysis and Forecast by Market Taxonomy
19.11.2.2.1. By Ingredients
19.11.2.2.2. By Dosage Form
19.11.2.2.3. By Route of Administration
19.11.2.2.4. By Indication
19.11.2.2.5. By Distribution Channel
19.11.3. South Korea Market Analysis
19.11.3.1. Introduction
19.11.3.2. Market Analysis and Forecast by Market Taxonomy
19.11.3.2.1. By Ingredients
19.11.3.2.2. By Dosage Form
19.11.3.2.3. By Route of Administration
19.11.3.2.4. By Indication
19.11.3.2.5. By Distribution Channel
20. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
20.4. Introduction
20.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
20.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
20.6.1. By Country
20.6.1.1. India
20.6.1.2. Indonesia
20.6.1.3. Malaysia
20.6.1.4. Thailand
20.6.1.5. Rest of South Asia
20.6.2. By Ingredients
20.6.3. By Dosage Form
20.6.4. By Route of Administration
20.6.5. By Indication
20.6.6. By Distribution Channel
20.7. Market Attractiveness Analysis
20.7.1. By Country
20.7.2. By Ingredients
20.7.3. By Dosage Form
20.7.4. By Route of Administration
20.7.5. By Indication
20.7.6. By Distribution Channel
20.8. Market Trends
20.9. Key Market Participants - Intensity Mapping
20.10. Drivers and Restraints - Impact Analysis
20.11. Country Level Analysis & Forecast
20.11.1. India Market Analysis
20.11.1.1. Introduction
20.11.1.2. Market Analysis and Forecast by Market Taxonomy
20.11.1.2.1. By Ingredients
20.11.1.2.2. By Dosage Form
20.11.1.2.3. By Route of Administration
20.11.1.2.4. By Indication
20.11.1.2.5. By Distribution Channel
20.11.2. Indonesia Market Analysis
20.11.2.1. Introduction
20.11.2.2. Market Analysis and Forecast by Market Taxonomy
20.11.2.2.1. By Ingredients
20.11.2.2.2. By Dosage Form
20.11.2.2.3. By Route of Administration
20.11.2.2.4. By Indication
20.11.2.2.5. By Distribution Channel
20.11.3. Malaysia Market Analysis
20.11.3.1. Introduction
20.11.3.2. Market Analysis and Forecast by Market Taxonomy
20.11.3.2.1. By Ingredients
20.11.3.2.2. By Dosage Form
20.11.3.2.3. By Route of Administration
20.11.3.2.4. By Indication
20.11.3.2.5. By Distribution Channel
20.11.4. Thailand Market Analysis
20.11.4.1. Introduction
20.11.4.2. Market Analysis and Forecast by Market Taxonomy
20.11.4.2.1. By Ingredients
20.11.4.2.2. By Dosage Form
20.11.4.2.3. By Route of Administration
20.11.4.2.4. By Indication
20.11.4.2.5. By Distribution Channel
21. Oceania Market 2019 to 2023 and Forecast 2024 to 2034
21.4. Introduction
21.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
21.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
21.6.1. By Country
21.6.1.1. Australia
21.6.1.2. New Zealand
21.6.2. By Ingredients
21.6.3. By Dosage Form
21.6.4. By Route of Administration
21.6.5. By Indication
21.6.6. By Distribution Channel
21.7. Market Attractiveness Analysis
21.7.1. By Country
21.7.2. By Ingredients
21.7.3. By Dosage Form
21.7.4. By Route of Administration
21.7.5. By Indication
21.7.6. By Distribution Channel
21.8. Market Trends
21.9. Key Market Participants - Intensity Mapping
21.10. Drivers and Restraints - Impact Analysis
21.11. Country Level Analysis & Forecast
21.11.1. Australia Market Analysis
21.11.1.1. Introduction
21.11.1.2. Market Analysis and Forecast by Market Taxonomy
21.11.1.2.1. By Ingredients
21.11.1.2.2. By Dosage Form
21.11.1.2.3. By Route of Administration
21.11.1.2.4. By Indication
21.11.1.2.5. By Distribution Channel
21.11.2. New Zealand Market Analysis
21.11.2.1. Introduction
21.11.2.2. Market Analysis and Forecast by Market Taxonomy
21.11.2.2.1. By Ingredients
21.11.2.2.2. By Dosage Form
21.11.2.2.3. By Route of Administration
21.11.2.2.4. By Indication
21.11.2.2.5. By Distribution Channel
22. Middle East and Africa (MEA) Market Analysis 2019 to 2023 and Forecast 2024 to 2034
22.4. Introduction
22.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
22.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
22.6.1. By Country
22.6.1.1. GCC Countries
22.6.1.2. Turkey
22.6.1.3. South Africa
22.6.1.4. North Africa
22.6.1.5. Rest of Middle East and Africa
22.6.2. By Ingredients
22.6.3. By Dosage Form
22.6.4. By Route of Administration
22.6.5. By Indication
22.6.6. By Distribution Channel
22.7. Market Attractiveness Analysis
22.7.1. By Country
22.7.2. By Ingredients
22.7.3. By Dosage Form
22.7.4. By Route of Administration
22.7.5. By Indication
22.7.6. By Distribution Channel
22.8. Market Trends
22.9. Key Market Participants - Intensity Mapping
22.10. Drivers and Restraints - Impact Analysis
22.11. Country Level Analysis & Forecast
22.11.1. GCC Countries Market Analysis
22.11.1.1. Introduction
22.11.1.2. Market Analysis and Forecast by Market Taxonomy
22.11.1.2.1. By Ingredients
22.11.1.2.2. By Dosage Form
22.11.1.2.3. By Route of Administration
22.11.1.2.4. By Indication
22.11.1.2.5. By Distribution Channel
22.11.2. Turkey Market Analysis
22.11.2.1. Introduction
22.11.2.2. Market Analysis and Forecast by Market Taxonomy
22.11.2.2.1. By Ingredients
22.11.2.2.2. By Dosage Form
22.11.2.2.3. By Route of Administration
22.11.2.2.4. By Indication
22.11.2.2.5. By Distribution Channel
22.11.3. South Africa Market Analysis
22.11.3.1. Introduction
22.11.3.2. Market Analysis and Forecast by Market Taxonomy
22.11.3.2.1. By Ingredients
22.11.3.2.2. By Dosage Form
22.11.3.2.3. By Route of Administration
22.11.3.2.4. By Indication
22.11.3.2.5. By Distribution Channel
22.11.4. North Africa Market Analysis
22.11.4.1. Introduction
22.11.4.2. Market Analysis and Forecast by Market Taxonomy
22.11.4.2.1. By Ingredients
22.11.4.2.2. By Dosage Form
22.11.4.2.3. By Route of Administration
22.11.4.2.4. By Indication
22.11.4.2.5. By Distribution Channel
23. Market Structure Analysis
23.4. Market Analysis by Tier of Companies
23.5. Market Share Analysis of Top Players (%)
23.6. Market Presence Analysis
23.6.1. By Regional Footprint of Players
23.6.2. Ingredients Footprint of Players
23.6.3. Channel Footprint of Players
24. Competition Analysis
24.4. Competition Dashboard
24.5. Competition Benchmarking
24.6. Competition Deep Dive
24.6.1. Pfizer Inc.
24.6.1.1. Overview
24.6.1.2. Ingredients & Services Portfolio
24.6.1.3. Key Financials
24.6.1.4. SWOT Analysis
24.6.1.5. Key Developments
24.6.1.6. Sales Footprint
24.6.1.7. Strategy Overview
24.6.1.7.1. Marketing Strategy
24.6.1.7.2. Ingredients Strategy
24.6.1.7.3. Channel Strategy
24.6.2. Novartis AG
24.6.3. Bausch & Lomb Incorporated.
24.6.4. Amway Corp.
24.6.5. Vitabiotics Ltd.
24.6.6. Alliance Pharma
24.6.7. The Nature's Bounty Co
24.6.8. ZeaVision, LLC.
24.6.9. Akorn Consumer Health
24.6.10. Eyescience Labs
24.6.11. Kemin Industries Inc.
24.6.12. NutraChamps
24.6.13. Nutrivein
24.6.14. Biosyntrx Inc
24.6.15. Nordic Naturals Inc.
24.6.16. Bristol-Myers Squibb Company
24.6.17. Healths Harmony LLC
24.6.18. NUSAPURE
24.6.19. Vitabiotics Ltd.
24.6.20. EyeScience
24.6.21. Butterflies Healthcare Ltd
24.6.22. Allergan plc
24.6.23. Herbalife Nutrition Ltd.
25. Assumptions and Acronyms Used
26. Research Methodology
Explore Healthcare Insights
View Reports
Eye Care Supplement Market
